INTRODUCTION
Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide, and South Korea has one of the highest prevalence rates for this disease. 1 Surgical resection is accepted as the most effective intervention to cure such patients. There are several reports on the risk factors for tumor recurrence after liver resection for HCC, mostly based on patient status, pathology results, and biological factors, irrespective of the surgical precision or procedure adopted. 2 When the extent and type of liver resection are considered, anatomic resection (AR) is theoretically superior to non-anatomic resection (NR) for patients with HCC because it can eradicate intrahepatic metastases that might have spread via portal tributaries. 3 However, the fear of further reducing the liver size causes surgeons to question the benefits of performing AR in a patient with cirrhosis.
Moreover, the superiority of this procedure for oncologic safety remains controversial. 4 ,5 Therefore, we retrospectively evaluated patient survival rates and recurrence patterns, and compared the post-hepatectomy liver function with the extent of liver resection in such patients.
MATERIALS AND METHODS
From March 2009 to February 2012, 184 patients underwent curative surgical resection for HCC at Kyungpook 
RESULTS

Patient characteristics
The clinical features of the 79 patients were listed in Table 1 . Comparing the AR group (n=31) versus the NR group (n=48), there were no significant differences in gender, age, the incidences of hepatitis B or C, AST or ALT levels, prothrombin time (PT), serum albumin, total bilir- 
Prothrombin time, % Albumin, g/dl Total bilirubin, mg/dl AFP＞200 ng/ml (present)* ICG R15, % Tumor size＞5 cm (present) (n) Resection margin≤10 mm (present) (n) Anatomic resection (n) Recurrence and survival outcomes After a median follow-up of 37.0 months (range 3-60)
post-resection, the 1-and 3-year overall and disease-free survival rates for all patients were 97% and 86%, and 85% and 64%, respectively (Fig. 1) .
Thirty patients (38%) had recurrence and 10 patients (Table 3) .
On the other hand, the extent of liver resection was not a significant risk factor for recurrence with the 1-and 3-year overall survival rates for the AR and NR groups of 97% and 82%, and 96% and 89%, respectively Patterns of tumor recurrence Twenty-two patients (28%) had tumors that recurred within 2 years after liver resection (10 patients after AR and 12 after NR) and the frequency of early recurrences was similar between the 2 groups (p=0.419). Regarding the pattern of recurrence, in the NR group, 2 patients had a recurrence at the liver transection margin (1 of these showed a marginal recurrence at 36 months after liver resection), 5 had a recurrence in an adjacent section, 3 in a distal section, 5 had a multi-sectional recurrence, and 3 developed extrahepatic recurrences. In the AR group, a marginal recurrence occurred in 1 patient. The other intrahepatic recurrences consisted of 2 at an adjacent section, 3 at a distal section, and 1 in multiple sections. Five patients had a recurrence at an extrahepatic site. There were no significant differences between the 2 groups with respect to the first site of recurrence or the pattern of intrahepatic recurrence (p=0.210 and p=0.734, respectively; Table 4 ).
Perioperative liver function
Biochemical liver function parameters were similar between the 2 groups during the preoperative period. However, the serum bilirubin level and PT value of the AR group were worse than those of the NR group during the postoperative period (Fig. 3) .
DISCUSSION
AR is theoretically ideal for a patient with HCC from functional and oncological aspects, because the related portal vein and corresponding hepatic territory are removed. This reduces the ischemic area, minimizes any bile leakage, and lessens the possibility of any local recurrence of the tumor. However, the removal of a larger liver volume in the AR vs. NR procedure raises the possibility that the remaining liver mass might not meet the patient's metabolic requirements. 9, 10 Therefore, several studies have aimed to evaluate the effects of the extent of surgery for HCC. 4, 5, [11] [12] [13] In 2014, 3 studies used propensity-matching score analysis with the aim of identifying any benefit in patient survival after AR. However, none of these found conclusive results despite efforts to minimize confounding factors; in fact, they reported three different results. Okamura et al. 14 showed that the overall and recurrence-free survival in patients with HCC infected with hepatitis C virus were not superior in AR than NR procedure. In contrast, Cucchetti et al. 15 showed a lower early recurrence rate for patients with unfavorable tumor features after AR; while Ishii et al. 16 showed a statistically significant difference in overall patient survival, but not in disease-free survival, after AR.
In this study, there were no significant disease-free or overall survival differences between the 2 groups. NR has a benefit in managing patients with HCC. First, by preserving the liver parenchyma as much as possible, postoperative liver function is better than AR, as indicated by our results. Second, the chance of performing multimodality treatment is higher on tumor recurrence, and repeat resections can be performed. Third, when salvage liver transplantation is considered, a prior AR might lead to difficulties in dissecting the hilum and severe adhesions, resulting in massive bleeding. 19 The present study had some limitations that must be taken into consideration. The small-scale, retrospective, observational nature of the study might have influenced the results, and some selection bias was inevitable.
Another limitation is that we did not analyze the gross classification of the tumors, which is a potential risk factor for recurrence. 20 Therefore, a large-scale prospective randomized trial would be ideal for investigating surgical outcomes according to the extent of hepatic resection.
In conclusion, the operative outcomes and the patterns of recurrence were similar between the AR and NR groups for treatment of a solitary HCC without macroscopic vascular invasion. In particular, marginal recurrences were negligible in both groups. Therefore, we suggested that NR could be a good alternative treatment op-tion for patients with a solitary HCC by balancing the need to maintain an adequate hepatic reservoir with oncologic clearance. However, further studies are required to confirm the effects of the extent of hepatic resection in such cases.
